Mercury Laboratories Limited (BOM:538964)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals Products	759.37M	751.01M	755.59M	753.34M	579.24M
Pharmaceuticals Products Growth	1.11%	-0.61%	0.30%	30.06%	-15.56%
Total	759.37M	751.01M	755.59M	753.34M	579.24M
Total Growth	1.11%	-0.61%	0.30%	30.06%	-15.56%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	542.58M	568.48M	562.57M	483.94M
India Growth	-4.56%	1.05%	16.25%	-4.13%
Export	208.43M	187.11M	190.77M	95.30M
Export Growth	11.39%	-1.92%	100.18%	-
Total	751.01M	755.59M	753.34M	579.24M
Total Growth	-0.61%	0.30%	30.06%	-15.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 5, 2026

Data Sources Report a data error